Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VCB-1206
- Development stage
- Preclinical
- Lead developer
- Vaxcell-Bio Therapeutics
- Modality
- CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
VCB-1206 is an investigational Chimeric Antigen Receptor Natural Killer (CAR-NK) cell therapy being developed by Vaxcell Bio. Currently in the preclinical stage, it is designed for the treatment of various autoimmune diseases. The therapy involves engineering natural killer cells to express a chimeric antigen receptor, allowing them to specifically target and eliminate pathogenic immune cells involved in the progression of autoimmune conditions. This approach aims to provide a more targeted and potentially safer alternative to traditional systemic immunosuppressive therapies by leveraging the innate cytotoxic capabilities of NK cells with enhanced specificity.
Beyond the preview
Go deeper on VCB-1206.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VCB-1206.